RaySearch has announced the release of RayStation® 9A*, the latest version of the innovative radiation therapy treatment planning system (TPS). RayStation 9A holds several improvements, supports additional machines and treatment techniques, as well as enhancements in the integration with the next generation oncology information system (OIS) RayCare®*.
RayStation 9A adds support for treatment machines with dual-layer multi-leaf collimator (MLC) and non-rotating jaws, which are properties of the Varian Halcyon™ machine. This feature is one more step towards RaySearch’s goal to unify treatment planning for as many treatment delivery machines and systems as possible, eliminating complications and additional steps that arise from using multiple software systems.
Another improvement is the support for directly deliverable multi-criteria optimization for VMAT for Varian machines, enabling the same possibility for these machines as Elekta machines have had since the release of RayStation 8B.
New for this release is also the improved machine modelling for photons, allowing diagonal profiles in the beam commissioning module of RayPhysics. Extended possibility to export VSim plans for further use in any treatment planning system is also new.
Improvements for proton therapy planning include caching of spot doses to speed up the optimization process. For carbon ion planning, support for Toshiba machines have been added. The microdosimetric kinetic model (MKM) for calculation of radiobiological equivalent (RBE) dose is included. This is an important step to support carbon ion treatments in Japan, where most of the current carbon ion facilities are located. Support for connectivity with the interface IONTRIS used for Siemens carbon ion machines has also been added.
RayStation 9A also includes several general improvements, such as support for 6D couch during planning. Enhancements in the integration with RayCare, such as automatic generation of treatment plans based on a patient’s diagnose, is also included.
Johan Löf, CEO of RaySearch, says: “RayStation 9A is an important release as we further strengthen the support for more machines and treatment techniques. RaySearch has always been a leader in the philosophy of a comprehensive cancer care, for which I’m proud. The support for yet another type of treatment machine and MKM are part of what we work hard to enable our current and future customers to take part of.”
About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch’s software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.
About RayCare
RayCare is designed to support the complex logistical challenges of modern oncology clinics. It represents the future of oncology information system technology, supporting the vision of one oncology workflow. Many cancer patients receive a combination of treatment types, and RayCare is designed to reflect that. It will efficiently coordinate activities in radiation therapy, chemotherapy and surgery and will offer advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. RayCare is being developed with tomorrow’s requirements for advanced analytics and decision support in mind.
About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59
peter.thysell@raysearchlabs.com